SHH and cancer: Investigations of cancer subgroups were performed conventionally by the following steps: (1) grouping co-expressed genes into molecular subgroups; (2) assigning patients into subgroups according to their molecular characteristics; (3) analyzing potential cancer-driving mechanisms (e.g. WNT, SHH) for the subgroups, and (4) investigating the average prognosis in each subgroup.